Remogliflozin is a potent sodium-glucose co-transporter subtype 2 (SGLT2) inhibitor with antihyperglycemic activity. Potential drug for treatment of type 2 diabetes.
PRODUCT PROPERTIES |
Formula: | | C23H34N2O7 |
MW: | | 450.53 |
CAS: | | 329045-45-6 |
Purity: | | ≥98% by HPLC |
Appearance: | | White solid. |
Solubility: | | DMSO (>40 mg/ml) |
Long Term Storage: | | -20°C |
Background / Technical Information: | | For the Original Manufacturer's data sheet please click here. |
|
|
|